Xiao‐Feng Le
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Pathology and Forensic Medicine top 10%
- Spine and Intervertebral Disc Pathology
Papers in
- Oncology 14
- HER2/EGFR in Cancer Research 5
- Cytokine Signaling Pathways and Interactions 3
- Cancer-related Molecular Pathways 3
- Co-authors
- Robert C. Bast (10 shared papers)Weiqun Mao (6 shared papers)George A. Călin (3 shared papers)Wei Tian (6 shared papers)Ju‐Yeon Kim (1 shared paper)Francisco J. Esteva (1 shared paper)Libero Santarpia (1 shared paper)Erica Moretti (1 shared paper)
- Journals
- Cancer Research (5 papers)Cancer (3 papers)Annals of Oncology (3 papers)World Neurosurgery (2 papers)Cellular Physiology and Biochemistry (2 papers)
- Partner nations
- United StatesChinaSouth Korea
In The Last Decade
Xiao‐Feng Le
29 papers receiving 887 citations
Peers
Comparison fields: 5 of 78
- Cancer Research 303
- Pathology and Forensic Medicine 202
- Molecular Biology 475
- Oncology 185
- Surgery 214
Countries citing papers authored by Xiao‐Feng Le
This map shows the geographic impact of Xiao‐Feng Le's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao‐Feng Le with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao‐Feng Le more than expected).
Fields of papers citing papers by Xiao‐Feng Le
This network shows the impact of papers produced by Xiao‐Feng Le. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao‐Feng Le. The network helps show where Xiao‐Feng Le may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiao‐Feng Le, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 221 | |
| 2 | 2018 | 97 | |
| 3 | 2010 | 71 | |
| 4 | 2004 | 58 | |
| 5 | 2012 | 58 | |
| 6 | 2019 | 54 | |
| 7 | 2011 | 47 | |
| 8 | 2010 | 41 | |
| 9 | 2012 | 37 | |
| 10 | 2016 | 35 | |
| 11 | 1998 | 28 | |
| 12 | 2022 | 27 | |
| 13 | 2009 | 23 | |
| 14 | 2019 | 21 | |
| 15 | 2021 | 15 | |
| 16 | 2018 | 14 | |
| 17 | 2022 | 6 | |
| 18 | 2020 | 6 | |
| 19 | 2022 | 6 | |
| 20 | Growth arrest induced by anti-HER2 antibody blocks breast cancer cells in the late G1 phase of the cell cycle | 2005 | 5 |
About Xiao‐Feng Le
Xiao‐Feng Le is a scholar working on Oncology, Molecular Biology, Pathology and Forensic Medicine, Surgery and Cancer Research, having authored 29 papers that have together received 891 indexed citations. Recurring topics across this work include Spine and Intervertebral Disc Pathology (8 papers), Spinal Fractures and Fixation Techniques (8 papers), HER2/EGFR in Cancer Research (5 papers), Lung Cancer Treatments and Mutations (4 papers), Cytokine Signaling Pathways and Interactions (3 papers), MicroRNA in disease regulation (3 papers), Medical Imaging and Analysis (3 papers) and Cancer-related Molecular Pathways (3 papers). The work is most often cited by research in Cancer Research (303 citations), Pathology and Forensic Medicine (202 citations), Molecular Biology (475 citations), Oncology (185 citations) and Surgery (214 citations). Xiao‐Feng Le has collaborated with scholars based in United States, China and South Korea. Frequent co-authors include Robert C. Bast, Weiqun Mao, George A. Călin, Wei Tian, Ju‐Yeon Kim, Francisco J. Esteva, Libero Santarpia, Erica Moretti, Angelo Di Leo and Lajos Pusztai. Their work appears in journals such as Cancer Research, Cancer, Annals of Oncology, World Neurosurgery and Cellular Physiology and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.